Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stimulant side effects: prefrontal/basal ganglia circuit control at dopamine D1/D2 receptors.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists - 1 Apr 2014

Levy Florence, Dadds Mark R

Abstract excerpt

BACKGROUND: While side effects of stimulant medication used to treat children for attention deficit hyperactivity disorder have been clinically described as mild but variable, there is little or no research or understanding of biological mechanisms involved. METHOD: The present short review extends the 'tonic-phasic' dopamine hypothesis in terms of prefrontal and subcortical dopamine receptor (D1/D2) imbalance....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Basal Ganglia
Share to Central Nervous System Stimulants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neural Pathways

Share to Prefrontal Cortex

Share to Receptors, Dopamine D1

Share to Receptors, Dopamine D2

Source

Identifiers

PMID: 24425798
DOI: 10.1177/1039856213517948

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stimulant side effects: prefrontal/basal ganglia circuit control at dopamine D1/D2 receptors.PMID 24425798Read ↗

The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal modelsSemantic proximity Read ↗

Dopamine transporter genotype influences the physiological response to medication in ADHD.Semantic proximity Read ↗

Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder.Semantic proximity Read ↗

[Pharmacological update in attention deficit hyperactivity disorder: models of intervention and new drugs].Semantic proximity Read ↗

Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Attention deficit hyperactivity disorder: current progress and controversies.Semantic proximity Read ↗

[Attention deficit hyperactivity disorder (ADHD): etiology, diagnosis and treatment].Semantic proximity Read ↗

Role of the norepinephrine transporter polymorphisms in atomoxetine treatment: From response to side effects in children with ADHD.Semantic proximity Read ↗

COMT x DRD4 epistasis impacts prefrontal cortex function underlying response control.Semantic proximity Read ↗

Influence of COMT (rs4680) and DRD2 (rs1076560, rs1800497) Gene Polymorphisms on Safety and Efficacy of Methylphenidate Treatment in Children with Fetal Alcohol Spectrum Disorders.Semantic proximity Read ↗

Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.